Outcomes following second allogeneic haematopoietic transplants using fludarabine-melphalan conditioning (Q48329297)

10 February 2018

http://europepmc.org/abstract/MED/24583626

title

Outcomes following second allogeneic haematopoietic transplants using fludarabine-melphalan conditioning (English)

1 reference

10 February 2018

http://europepmc.org/abstract/MED/24583626

author

Ian Bilmon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24583626 AND SRC:MED&resulttype=core&format=json

8 June 2020

author name string

I Nivison-Smith

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24583626 AND SRC:MED&resulttype=core&format=json

8 June 2020

M Hertzberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24583626 AND SRC:MED&resulttype=core&format=json

8 June 2020

D Ritchie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24583626 AND SRC:MED&resulttype=core&format=json

8 June 2020

M Greenwood

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24583626 AND SRC:MED&resulttype=core&format=json

8 June 2020

A Spencer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24583626 AND SRC:MED&resulttype=core&format=json

8 June 2020

G Kennedy

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24583626 AND SRC:MED&resulttype=core&format=json

8 June 2020

A Bryant

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24583626 AND SRC:MED&resulttype=core&format=json

8 June 2020

J Moore

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24583626 AND SRC:MED&resulttype=core&format=json

8 June 2020

language of work or name

English

0 references

publication date

3 March 2014

1 reference

10 February 2018

http://europepmc.org/abstract/MED/24583626

published in

Bone Marrow Transplantation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24583626 AND SRC:MED&resulttype=core&format=json

8 June 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24583626 AND SRC:MED&resulttype=core&format=json

8 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24583626 AND SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

852-853

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24583626 AND SRC:MED&resulttype=core&format=json

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant

8 June 2020

cites work

1 reference

Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change

21 January 2018

1 reference

ASH evidence-based guidelines: is there a role for second allogeneic transplant after relapse?

21 January 2018

1 reference

A retrospective review of the outcome after second or subsequent allogeneic transplantation

21 January 2018

1 reference

Fludarabine Melphalan reduced-intensity conditioning allotransplanation provides similar disease control in lymphoid and myeloid malignancies: analysis of 344 patients

21 January 2018

1 reference

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant.

21 January 2018

1 reference

Nonmyeloablative second transplants are associated with lower nonrelapse mortality and superior survival than myeloablative second transplants

21 January 2018

1 reference

12 December 2020

Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation

1 reference

12 December 2020

Reduced-intensity conditioning regimens for hematologic malignancies: what have we learned over the last 10 years?

1 reference

12 December 2020

Nonmyeloablative allogeneic stem cell transplantation (NST) after truly nonmyeloablative and reduced intensity conditioning regimens

1 reference

12 December 2020